Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer

NCT00081289 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

146

Enrollment

NETWORK

Sponsor class

Conditions

Colorectal Cancer

Interventions

RADIATION: Radiation Therapy
DRUG: Capecitabine 1650 mg/m^2/day
DRUG: Capecitabine 1200 mg/m^2/day
DRUG: Irinotecan
DRUG: Oxaliplatin
PROCEDURE: Surgery
DRUG: Folinic Acid
DRUG: Fluorouracil
DRUG: Oxaliplatin

Sponsor

Radiation Therapy Oncology Group

Collaborators

[object Object]